Because Mcl-1 is the most overexpressed anti-apoptotic gene in senescent cancer cells, including Bcl-2-negative senescent tumor cells, pharmacologically suppressing Mcl-1 can ultimately eradicate senescent prostate cancer cells, preventing the spread of the tumor and metastases. Here, MCL1 is linked to prostate carcinoma.